Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Absence of CYP2B6 promoter -82T>C mutation in Chinese as an additional factor for slow metabolism of drugs commonly used in infections.

European journal of clinical pharmacology - 1 Jul 2006

He Ming-Liang, Lin Ck, Tong Kenneth, Xu Bingying, Sung Joseph Jy, Kung Hsiang-Fu, Lee Shui-Shan

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Infective Agents
Share to Aryl Hydrocarbon Hydroxylases
Share to Cytochrome P-450 CYP2B6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytosine

Share to Infections

Share to Oxidoreductases, N-Demethylating

Share to Pharmacogenetics

Share to Thymine

Source

Identifiers

PMID: 16770645
DOI: 10.1007/s00228-006-0163-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Absence of CYP2B6 promoter -82T>C mutation in Chinese as an additional factor for slow metabolism of drugs commonly used in infections.PMID 16770645Read ↗

R296C and other CYP2D6 mutations in Chinese.Semantic proximity Read ↗

Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.Semantic proximity Read ↗

Genetic polymorphisms of metabolic enzymes and the pharmacokinetics of indapamide in Taiwanese subjects.Semantic proximity Read ↗

Genetic polymorphisms of cytochrome P450 2B6 gene in Han Chinese.Semantic proximity Read ↗

The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 in Taiwanese population.Semantic proximity Read ↗

[Advances in the study of pharmacogenetics in China in 1996].Semantic proximity Read ↗

Pharmacogenetics of common SNP affecting drug metabolizing enzymes: comparison of allele frequencies between European and Malaysian/Singaporean.Semantic proximity Read ↗

Population Differences in Major Functional Polymorphisms of Pharmacokinetics/pharmacodynamics-related Genes in Eastern Asians and Europeans: Implications in the Clinical Trials for Novel Drug DevelopmentSemantic proximity Read ↗

Frequency Evaluation of T6235C (m1) and A4889G (m2) Polymorphisms of CYP1A1 Gene in a Healthy Population from the west of Mazandaran Province, Iran.Semantic proximity Read ↗

Combination Analysis in Genetic Polymorphisms of Drug-Metabolizing Enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese PopulationSemantic proximity Read ↗

Allele and genotype frequencies of CYP2B6 in a Turkish population.Semantic proximity Read ↗

G-2964A and C734A genetic polymorphisms of CYP1A2 in Chinese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.